The extended-release formulation exenatide once-weekly (Bydureon) can be given at any time of day, with or without meals, on the same day each week
Common side effectsnausea, vomiting, constipation, and loss of appetiteare dose-dependent and often decrease over time as your body adjusts
The compound features a modified peptide backbone with a fatty-acid side chain that extends its half-life relative to native GLP-1
The highly expressed protein convertase Furin inhibits intestinal epithelial cell damage in a rat model of UC by activating the Nrf2Gpx4 pathway, thus alleviating the symptoms of UC
The longer lines usually mark every 10 units
The prognosis for oral cancer remains poor, with an overall five-year survival rate as low as 40%